| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |